STAT Plus: CEO Daniel O’Day explains why Gilead paid $4.9 billion for Forty Seven March 2, 2020 STAT Off Biotech, biotechnology, Business, cancer, coronavirus, durg development, Human Health, Life Sciences, Medicine, Science and Research, STAT Plus 000000000000Gilead’s board hired CEO Dan O’Day a year ago to look for new areas of…